title: Severe combined immunodeficiency mice engrafted with human T cells, B cells, and myeloid cells after transplantation with human fetal bone marrow or liver cells and implanted with human fetal thymus: a model for studying human gene therapy.
abstract: To develop an in vivo model wherein human hematopoiesis occurs, we transplanted severe combined immunodeficiency (SCID) mice with either human fetal bone marrow (HFBM) or human fetal liver (HFL). After transplantation of SCID mice with cultured HFBM (BM-SCID-hu mice) or HFL cells (Liv-SCID-hu mice), significant engraftment of the mouse bone marrow (BM) and population of the peripheral blood with human leukocytes was detected. Human colony-forming unit-granulocyte macrophage and burst forming unit-erythroid were detected in the BM of the BM-SCID-hu and Liv-SCID-hu mice up to 8 months after transplantation. When the HFBM or HFL cells were transduced with a retroviral vector before transplantation, integrated retroviral sequences were detected in human precursor cells present in the SCID mouse BM and in leukocytes circulating in the peripheral blood (PB) up to 7 months after transplantation. The PB of the BM-SCID-hu mice also became populated with human T cells after implantation with human thymic tissue, which provided a human microenvironment wherein human pre-T cells from the BM could mature. When the HFBM was retrovirally transduced before transplantation, integrated retrovirus was detected in sorted CD4+CD8+ double positive and CD4+ single positive cells from the thymic implant and CD4+ cells from the PB. Taken together, these data indicated that the BM of our BM-SCID-hu and Liv-SCID-hu mice became engrafted with retrovirally transduced human hematopoietic precursors that undergo the normal human hematopoietic program and populate the mouse PB with human cells containing integrated retroviral sequences. In addition to being a model for studying in vivo human hematopoiesis, these mice should also prove to be a useful model for investigating in vivo gene therapy using human stem/precursor cells.
authors.affiliation: Department of Pediatrics, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
authors.forename: S
authors.initials: S
authors.lastname: Yurasov
authors.forename: T R
authors.initials: TR
authors.lastname: Kollmann
authors.forename: A
authors.initials: A
authors.lastname: Kim
authors.forename: C A
authors.initials: CA
authors.lastname: Raker
authors.forename: M
authors.initials: M
authors.lastname: Hachamovitch
authors.forename: F
authors.initials: F
authors.lastname: Wong-Staal
authors.forename: H
authors.initials: H
authors.lastname: Goldstein
mesh_terms: D000818:Animals; D001402:B-Lymphocytes / Q000637:transplantation*; D001772:Blood Cell Count; D016026:Bone Marrow Transplantation; D002454:Cell Differentiation; D016332:Fetal Tissue Transplantation; D015316:Genetic Therapy; D006085:Graft Survival; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D016031:Liver Transplantation; D051379:Mice; D016513:Mice, SCID; D013601:T-Lymphocytes / Q000637:transplantation*; D013950:Thymus Gland / Q000637:transplantation*